Scholarly article on C36H32Br2 17868-26-7 from Bulletin of the Chemical Society of Japan p. 652 - 655

DOI: 10.1246/bcsj.41.652

Source and publish data:

Bulletin of the Chemical Society of Japan p. 652 - 655 (1968)

Update date:2022-08-02

Topics:

Authors:

Inazu,T.

Yoshino,T.

Read Full Text PDF DownLoad Join now for total 90,000,000 free articles

Article abstract of DOI:10.1246/bcsj.41.652

Full text of DOI:10.1246/bcsj.41.652

Products guided by the article

Product name:C₃₆H₃₂Br₂

Cas No:17868-26-7

R&D Labs maybe for 17868-26-7

Jinan Hongfangde Pharmatech Co.LTD

Contact:0531-88870908

Address:F Bldg,750#,Shunhua Rd,New&High-tech Zone,Jinan,Shandong,China 250101
Synchem Pharma Co.,Ltd(expird)

Contact:+0086-21-61984905-1

Address:Building 60,Zimian Park, LongYang industrial Area, 1515Nong，Yuandong Road Fengxian District, Shanghai ,China
Shanghai PotentPharm Science and Technology Co.,Ltd

Contact:86-021-51969655

Address:Unit B, Building 18, No.300, Chuantu Rd,Pudong District, Shanghai 201202, China
NanJing Rate Biochemicals CO., LTD

Contact:+86-25-84931986

Address:NO. 1 Hongjing Road,Jiangning Science Park,Nanjing,China
Fuxin Jintelai Fluorin Chemical Co., Ltd.

Contact:+86-0418-8229599

Address:, 7th Huagong Road, Fluorine industry development zone (Yimatu Town,Fumeng County),Fuxin City, Liaoning Province, China

Relevant to this article

Discovery of a type III inhibitor of LIM kinase 2 that binds in a DFG-out conformation

Doi:10.1021/ml500242y
(2015)
Doi:10.1002/zaac.19592990513
(1959)
Water soluble prodrug of a COX-2 selective inhibitor suitable for intravenous administration in models of cerebral ischemia

Doi:10.1016/j.bmcl.2005.05.002
(2005)
Doi:10.1021/ie50527a046
(1953)
Synthesis and antineoplastic activity of combretastatin analogues: Heterocombretastatins

Doi:10.1016/S0223-5234(99)80078-6
(1998)
Synthesis of Guanidino-N-alkylarginines by the Use of Polymeric Pseudoureas

Doi:10.1021/jo00317a033
(1981)

Article Doi

DOI: 10.1246/bcsj.41.652